UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026
Globe Newswire•27/10/2026•18:00 ET
2
Key Highlights
- ➤UroGen (URGN) will report third-quarter 2026 financial results November 4 before market open
- ➤UroGen’s earnings webcast and conference call begin at 10:00 AM Eastern Time
- ➤UroGen says its RTGel platform is designed for sustained urinary-tract drug exposure
PRINCETON, N.J., Oct. 27, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report third quarter 2026 financial results on Wednesday, November 4(th), 2026, prior to the open of the stock market. The announcement will be followed by a live audio webcast and conference call at 10:00 AM Eastern Time.
A live public webcast of the earnings conference call can be accessed on UroGen’s Investor Relations website. Following the live webcast, a replay will be available on the site for approximately 30 days.
Get started
Create a free account to read the full story.